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Abstract
Neonatal Abstinence Syndrome is a set of
symptoms that result from prenatal exposure to addictive drugs. This syndrome is often attributed
to opiate withdrawal; yet, there is a controversy
within the literature as to whether cocaine, an addictive stimulant, leads to a variant, which I term
“cocaine-based Neonatal Abstinence Syndrome.”
In this paper, I contrast the evidence that supports
the presence of cocaine withdrawal in neonates
with the opposing evidence that supports its absence. I offer an intermediary explanation through
the “Adaptationist View,” which attributes the supposed symptoms of cocaine infant withdrawal to
the neonate adapting to extreme changes in its environment. Moreover, I introduce the Addictiveness of Cocaine Conclusion to serve as a logical
means to bridge the addiction cycle with the Adaptationist view.

1. Introduction
Neonatal Abstinence Syndrome (NAS), historically known as “infant addiction” and “congenital addiction,” describes a body of symptoms
experienced by an infant as a result of maternal
drug abuse over the course of a pregnancy (Jones
& Fielder 2015). The symptoms that arise are
the result of defects in the central nervous system
(CNS), autonomic nervous system (ANS), gas-
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trointestinal (GI) system, and respiratory system.
Specifically what symptoms arise and their severity are dependent on the drugs used and when the
pregnant mother uses them. Historically, NAS has
been diagnosed in the context of opiates, yet it
is controversial as to whether infants experience
withdrawal when they have been exposed to cocaine prenatally (Jones & Fielder 2015). In pursuing the possible existence of infant cocaine withdrawal, I will refer to cocaine-based neonatal abstinence syndrome as “cNAS.”
While the focus of this paper is to discuss the
relationship between neonates and cocaine withdrawal, it is important to describe the effect of cocaine on neurotransmitters and the placenta; understanding the physiological effects of cocaine
will provide context for symptoms. Cocaine
is a CNS stimulant that inhibits norepinephrine
transporters, serotonin transporters and dopamine
transporters, preventing the reuptake of synaptic norepinephrine, serotonin, and dopamine respectively (Cain, Bornick, and Whiteman 2013).
As these neurotransmitters are not removed in a
timely manner, they remain in excess in the synaptic cleft and elicit a signal upon binding to their
corresponding receptors on post-synaptic neurons.
This signal, known as an action potential, ultimately leads to effects that are dependent on the
neurotransmitter. The high concentration of neurotransmitters lead to the overstimulation of postsynaptic neurons; hence cocaine’s classification as
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a stimulant.
Every neurotransmitter has a corresponding effect. Due to the inhibition of mechanisms that reuptake norepinephrine, serotonin,
and dopamine, cocaine creates an imbalance in
these neurotransmitters. This dysregulation leads
to the symptoms of cocaine-use. Norepinephrine
is responsible for activating the sympathetic nervous system. The activation of the sympathetic
nervous system increases blood flow that is directed from the GI tract and reproductive system
to the heart, brain, and skeletal muscles (Buckley
2015). Serotonin is the prominent neurotransmitter that affects mood. Like cocaine, selective serotonin reuptake inhibitors (SSRIs) keep serotonin
in the synaptic cleft. Due to its function in maintaining high serotonin levels within the synaptic
cleft, there are similar arguments as to whether
SSRIs lead to neonate withdrawal when used over
the course of a pregnancy (Jones & Fielder 2015).
Dopamine is attributed to the feeling of euphoria,
colloquially known as a “high” (Cain, Bornick &
Whiteman 2013; Kuczkowski 2003, 2004, 2005).
Excess dopamine in the nucleus accumbens is the
biologically evident site of addiction. Cocaine increases the production of enzymes that decrease
dopamine levels. This increase in enzymes is a
response to the abnormally high concentration of
dopamine in the synaptic cleft. The body adapts
and synthesizes more enzymes in order to counteract future imbalances. Thus, the body becomes
less sensitive to dopamine; more precisely, it now
takes more dopamine to experience euphoria. In
the context of cocaine addiction, the user now
requires more cocaine in order to attain a high
enough dopamine concentration to experience euphoria.
As an extension to neurotransmitters, cocaine
directly affects the placenta. The placenta is
the site of maternal-fetal exchange. Within this
exchange, the placenta transfers nutrients from
mother to fetus, eliminates fetal metabolic waste,
mediates fetal gas exchange, and produces steroid
hormones. Effectively, the placenta serves as the
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fetal equivalent to the kidneys, the liver, and the
lungs (De Giovanni & Marchetti 2012). Considering its wide-ranging utility, the placenta is the
medium through which the mother prenatally provides the neonate with the necessary nutrients to
support its growth and development (Coyle, et al.
2018).
Cocaine acts on the placenta due to the presence of surface norepinephrine and serotonin receptors. The surface norepinephrine receptors act
in tandem with the mother’s sympathetic nervous
system. This connection is one of the reasons that
cocaine-use during pregnancy has an increased
risk for preterm rupturing of the membranes—
colloquially known as “the water breaking early.”
This risk is due to the overstimulation of norepinephrine receptors that line the face of the placenta. As cocaine activates the sympathetic nervous system and there is an increase in norepinephrine, uterine contractions occur as the pregnant mother enters preterm labor (De Giovanni
& Marchetti 2012). The constant stimulation of
the sympathetic nervous system effectively pushes
the neonate into delivery. The increase in norepinephrine is characteristic of a “catecholamine 1
surge” that occurs during birth and is speculated
to be the mechanism in which the infant adapts
to hypoxia during delivery (Buckley 2015). Additionally, there are higher levels of catecholamines
in umbilical arterial blood during vaginal delivery than in caesarean sections, indicative of its
use during stressful environments (Faxelius, et al.
1983). Regarding the use of serotonin, this neurotransmitter is transported to the fetus to regulate brain development, namely thalamocortical
wiring in the forebrain, cortical development, and
long-term behavior (Velasquez, et al. 2013).
Considering the potent effects of cocaine in
both the placenta and the fetus, the presence of
withdrawal from prenatal maternal cocaine use,
1 The term catecholamine describes a class of structurally

similar monoamine neurotransmitters. Among these neurotransmitters, norepinephrine and dopamine are a part of this
class. Serotonin is not.
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i.e. cNAS, is a point of controversy within the literature (Jones & Fielder 2015). It is logical to deduce that infants that were prenatally exposed to
cocaine experience withdrawal. A deductive argument that aptly represents this view can structured
such that:
1. Some drugs are addictive.
2. Users of addictive drugs become addicted after repeated use.
3. Removal of addictive drugs from an addicted
user leads to withdrawal.
4. Cocaine is an addictive drug.
5. Therefore, the removal of cocaine from an
addicted user leads to withdrawal.
I will label this argument the Addictiveness of
Cocaine Conclusion (ACC). This argument is
commonsensical; if an addictive substance is removed from its timely abuser, then withdrawal
follows. The ACC is described in part from the
addiction cycle, which considers three interconnected phases: intoxication, withdrawal, and preoccupation (Herman & Roberto 2015). In intoxication, the addictive substance is consumed,
prompting psychological and physiological effects, e.g. pleasure that stimulates the reward circuit in the brain. In withdrawal, an unpleasurable
state is sustained after the addictive substance is
removed for a period of time. Preoccupation is the
state in which an addicted user craves the addictive
substance after a period of abstinence. While addiction has been heavily researched in both human
and non-human subjects (Koob & Le Moal 1997),
there still remains a discrepancy as to whether
cocaine-exposed neonates experience withdrawal.
I will consider the ACC in response to whether
withdrawal exists in cocaine-exposed infants.
In this paper, I will present two viewpoints,
labeled “Study A” and Study “B”. In Study
A, I discuss evidence derived from a retrospective case-control study that concludes that withdrawal occurs in infants prenatally exposed to
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cocaine; their conclusion is derived through a
symptom-based definition of withdrawal (Ogunyemi & Hernández-Loera 2004). In Study B, I
discuss evidence derived from a cross-sectional
case-control study that concludes that withdrawal
does not occur in infants prenatally exposed to cocaine; their conclusion is derived through a standardized scale (Eyler, et al 2001). The purpose
of defining each view as “Study A” and “Study
B” is to utilize a representative argument in favor
of each perspective. Among the different articles
supporting either side of the argument, the article by Ogunyemi & Hernández-Loera in 2004 and
Eyler, et al in 2001 were used as exemplars to support the presence and absence of cocaine neonate
withdrawal respectively. Figure 2 under Conclusion and Discussion provides explicit differences
between the two representative studies. Additionally, other supporting articles were considered in
order to supplement both arguments provided in
Studies A and B. In light of these opposing views,
I conclude with the “Adaptationist View” to unite
both views while responding to the ACC.
2. Comparison of Methods between Parent
Studies
Study A: Source of Data, Definition of Withdrawal, and Methodology
Study A utilizes a retrospective case-control
study. In this study, cNAS was defined as
“neurobehavioral abnormalities, including greater
irritability, hypertonicity, tremulousness, mood
alterations and inconsolability” (Ogunyemi &
Hernández-Loera 2004). Thus, the presence of cocaine neonate withdrawal is determined on the basis of observed symptoms.
Study A’s cases included 253 pregnant women
with neonates that were diagnosed with prenatal
cocaine exposure and selected from the study’s
Division of Obstetrics database. The control
group was determined through a random selection
of 237 pregnancies with neonates that have no his-
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tory of prenatal cocaine exposure from the same
database. Of the selected, 53 cocaine-exposed and
37 non-exposed maternal-neonatal charts were excluded from the analysis as a result of incomplete records. Each chart of the selected maternalneonate pair was then reviewed for the following pieces of information: maternal age, gravidity, parity, race, onset of prenatal care, medical
history, obstetric and gynecological history, educational level, employment, marital status, legal problems, living conditions, urine toxicology
results, routine prenatal laboratory data, obstetric complications, delivery records and neonatal
complications. If the maternal-neonatal chart did
not possess these variables, they were excluded
from the analysis and were considered incomplete
(Ogunyemi & Hernández-Loera 2004).
Data analysis was undertaken through an
SPSS statistical program with categorical variable
relationships being tested for significance through
chi squared analysis. T-tests, variance, and
linear regression were used as needed. Multiple
logistic regression was also used for multivariable
analysis. A p-value less than 0.05 and a 95%
confidence interval was considered statistically
significant (Ogunyemi & Hernández-Loera 2004).
Study B: Source of Data, Definition of Withdrawal, and Methodology
Study B was a cross sectional case-control
study. In this study, cNAS was defined as the
lack of improvement or the worsening of cocaine
metabolite-positive infants following the removal
of cocaine (Eyler, et al 2001). Thus, the presence of cocaine neonate withdrawal is determined
from significantly lower scores for varying qualitative data of cocaine metabolite-positive neonates
contrasted with the data from an exposed cocaine
metabolite-negative group and non-exposed control group.
Study B selected 74 cocaine-exposed neonates
and 81 nonexposed neonates. The selectivity of
the study is described in Table 1.
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Table 1. Study B’s selection of controls and cocaine exposed infants.

Urine toxicology was used to differentiate cocaine exposed neonates at birth. Infants testing
“cocaine–” for cocaine metabolites was indicative
of the fact that cocaine was not found in the infant’s system. Infants testing “cocaine+” for cocaine metabolites was indicative of the fact that
cocaine was found in the infant’s system. The
reason why urine toxicology is nominally used
is because cocaine, after consumption, is eventually broken down in the body and removed
through the infant’s excretory system. Of the cocaine exposed neonates, 47 tested cocaine– and 27
tested cocaine+ at birth. Neonates that were born
preterm or by cesarean section were disqualified
to avoid confounding factors (Table from Eyler, et
al 2001).
Data analysis was undertaken to compare categorical variable relationships for significance
through chi squared analysis and t-tests. In particular, these variables were graded using the
Brazelton Neonate Behavior Assessment Scale
(NBAS). Significant differences in correlative
studies among mean levels by group or by time
were determined through ANOVA (Eyler, et al
2001).
3. Results
Study A indicated that cocaine-users, on average, delivered their infants earlier than the controls, i.e. at 36 weeks versus 39 weeks, with
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birth weights significantly lower than their control
counterparts, i.e. 2660 grams versus 3305 grams.
Fetal death had only occurred in the cocaine-using
sample. 131 cocaine-exposed infants tested cocaine+ in the womb with 75 of these infants fitting
the criteria to be diagnosed with neonatal abstinence syndrome after birth. The average time that
cocaine metabolites remained in the urine toxicology tests was 3.16 days after birth (Ogunyemi &
Hernández-Loera 2004).
Study B revealed that only autonomic regulation scores differed significantly between the
groups at birth. The data that was not controlled
for the effects of other drugs—i.e. marijuana, alcohol, and tobacco—indicated that there were significant differences in alert responsiveness, regulatory capacity, state regulation, and reinforcement value as shown in Table 2.
Table 3. Chart depicting the mean regulation state
scores for each of the three groups over time.
State regulation score is also given as a function
of time in a graphical representation. (Figures from
Eyler, et al. 2001)

Table 2. The results of Study B that did not control
for the effects of other drugs. In controlling their
effects, the data reveals that autonomic regulation
was the only source of significant difference from
one another. (Table from Eyler, et al. 2001)

nificant difference among the three groups. From
Days 2 to 4, the cocaine+ group had a significantly
higher regulation state score than both the control
group and cocaine– group. For the data between
Days 5 to 7, the cocaine+ group was significantly
lower than the control group but not significantly
different than the cocaine– group.
4. Conclusion and Discussion

Of the 27 cocaine+ infants, 79% remained
positive between Days 2–4 with none testing positive between Days 5–7. In analyzing NBAS scores
over time, the regulation state was the only statistically significant change over time when contrasted
between the cocaine-exposed groups and the control group. Figure 1 depicts the actual NBAS
scores and a pictorial representation of tested regulation state scores of the groups over time.
Within the data depicted in Figure 1, it is important to note that on Day 1, there was no sig-
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Study A concluded that 75 of the 131
cocaine-exposed infants were afflicted with cNAS.
Namely, this diagnosis of cNAS was undertaken
through the observation of specific symptoms.
These symptoms focused on neurobehavioral abnormalities such as hyperirritability, hypertonicity, tremulousness, mood alterations and inconsolability (Ogunyemi & Hernández-Loera 2004).
Concurrent with these observations, Ogunyemi &
Hernández-Loera found that cocaine– infants of-
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ten did not meet the criteria to be diagnosed with
cNAS. Instead, they proposed the idea of an “in
utero withdrawal,” i.e. the concept that cocaine–
infants at birth did not display withdrawal symptoms because they had already experienced withdrawal in the womb. The authors came to this
suggestion by analyzing both maternal urine toxicology and neonatal urine toxicology. In finding
trends within neonatal toxicology, they found that
if the urine sample had resulted in a positive test
for only one day or outright negative for cocaine
metabolites postnatally, withdrawal was unlikely
to be observed. In contrast, if the urine sample had
resulted in a positive test for two days or longer
postnatally, neonatal withdrawal was more likely
to be observed. The authors attribute this discrepancy to the time taken between the last administration of cocaine and delivery. If the infant was
cocaine+ for one day or cocaine– at birth, it is suggested that the mother’s last dose was one week
or earlier prior to delivery. In this instance, withdrawal would have occurred in utero. If the infant was cocaine+ for greater than two days postnatally, it is suggested that the mother’s last dose
was two to seven days prior to delivery. Thus,
the infant would exhibit symptoms that resemble
withdrawal postnatally (Ogunyemi & HernándezLoera 2004).
Study A is particularly convincing in that it
provides an explanation as to why some cocaineexposed neonates do not display withdrawal
symptoms. The study draws a distinction between
cocaine+ and cocaine– infants, where the former
group is proposed to experience withdrawal in
utero and the latter experiences withdrawal postnatally. The results of Study A are also supported by other studies that have diagnosed mild
to moderate withdrawal based on observed behavior (Cherukuri, et al. 1988; va de Bor, et al. 1990;
Mastrogianis, et al. 1990). Studies have also
supported Study A’s conclusion through a standardized scale, i.e. Finnegan’s Neonatal Abstinence Scoring System (Fulroth, Phillips & Durand 1989; Terri, et al. 1995). It is important to
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recognize, however, that this system is nominally
used to diagnose opioid NAS, which bears different symptoms than cocaine addiction and cocaine
withdrawal (Eyler, et al. 2001). Thus, the reliability of these results are questionable as to whether
the scores were the result of cNAS or simply an
overall effect of cocaine.
Study B suggests otherwise. While Study
A concludes with the presence of neonate withdrawal in utero and postnatally, Study B statistically concludes that cocaine– and cocaine+ infants are not significantly different from one another as denoted by their NBAS score; thus, the
evidence supports the idea that the generally lower
scores of cocaine-exposed infants relative to the
nonexposed infants is an overall effect of cocaine. This approach is convincing because NBAS
is a standardized evaluation that has the capacity to measure behaviors that are commonly attributed to cocaine exposure. Thus, the usage of
this evaluation provides a standardized means for
diagnosing cNAS. In analyzing the results, the
lack of a statistical significance between cocaine+
and cocaine– symptoms leads to the conclusion
that withdrawal does not occur within neonates
exposed to cocaine. Instead, the results indicate that, when contrasted with the behavior of
the control group, cocaine-exposed groups experience intransient defects due to the influence of
cocaine on an infant’s neurobehavioral pattern.
This view is supported through observational studies (Chiriboga 1993; Hadeed & Siegel 1989) and
through Finnegan’s Neonatal Abstinence Scoring system (Ryan, Ehrlich, and Finnegan 1987).
Again, it is important to note that Finnegan’s system was primarily used to diagnose opiate NAS
rather than cNAS. Moreover, it is also noteworthy
that the creator-namesake of this system, Loretta
Finnegan, also concluded the lack of cocaine withdrawal in infants (Ryan, Ehrlich, and Finnegan
1987). Both views are outlined and contrasted in
Figure 2.
Considering both studies aptly describe different perspectives regarding the existence of cNAS,

6

Cadiente: Adaptationist View

Table 4. A Comparison of Study A (Ogunyemi & Hernández-Loera 2004) and Study B (Eyler, et al. 2001).
Notice the conclusion column for a summary of both studies’ main point.

the question arises as to whether both views can be
united. Study A is reasonable when a symptomcentric perspective is considered, where specific
defects are a result of cNAS. The downfall from
this study, however, is the inability to distinguish
the symptoms of withdrawal from the direct effects of cocaine. Likewise, Study B is reasonable
when a scale-centric perspective relative to a control is considered, where lower NBAS scores compared to controls are the result of cocaine’s direct
effects rather than withdrawal. The concern for
Study B, however, is that this conclusion is counterintuitive. Recall the logic behind the ACC: the
removal of an addictive drug from a user leads
to withdrawal. Neonates are exposed to cocaine
with the substance flowing in and out of their system; how can the exposed infant seemingly be immune to withdrawal from cocaine, an addictive
substance? The answer is that they are not immune to withdrawal and this question can be approached by uniting both perspectives through the
“Adaptationist View”.
The Adaptationist View begins with the
maternal-fetal connection of the placenta. The
effects of cocaine stimulate the sympathetic ner-
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vous system. As a result of the active sympathetic
nervous system, less blood flows to the placenta.
Thus, less oxygen, hormones, and nutrients arrive
at the fetus (Messiah, et al. 2011; Nathanielsz
& Hanson 2003). Due to this low supply, the
exposed neonate does not possess comparative
amounts of nutrients or oxygen in order to grow at
a similar rate to unexposed neonates; this concept
is evident in that cocaine exposed neonates, on
average, weigh less than nonexposed neonates as
birth (Ogunyemi & Hernández-Loera 2004; Chiriboga et al., 1999; Bandstra et al., 2001; Bada et
al.,2002; Nordstrom-Klee et al., 2002). Thus, the
fetus adapts to this state by growing accustomed
to its low-resource environment. It is of interest to note that as hypoxia occurs during labor,
norepinephrine is in high concentration as part of
the catecholamine surge in order to adapt to this
state (Buckley 2015). Though I am not claiming
that cocaine-exposed infants become hypoxic per
se, they do utilize a comparatively lower supply
of oxygen; thus, neonates are forced into making
necessary adjustments, i.e. less expenditure of energy and devoting less resources for growth. Norepinephrine is the principal hormone for long-term
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adaptation. Moreover, dopamine has recently become a prominent treatment for neonate hypotension due to its capacity to increase blood pressure,
circulating more oxygen (Bhayat, et al 2016). In
this low-resource state, the neonate adapts to cocaine use at the expense of size and neurobehavioral development.
Upon birth, this adapted, maintained state is
disturbed. In particular, the neonate is not reliant on the mother’s blood supply and is thus
exposed to an excess of environmental oxygen.
With this significant amount of oxygen, the infant is overstimulated and ill-informed as to what
he or she ought to do with this excess energy.
Thus, the symptoms of hyperirritability, hypertonicity, and tremulousness arise. With an excess
amount of oxygen, the body also must readjust
to the higher concentrations of usable dopamine,
readapting from its adapted cocaine-exposed state.
This excess dopamine leads to the observed mood
alterations and inconsolability described in Study
A.
Upon the excretion of the cocaine metabolites,
the Adaptationist View would posit that the body
attempts to recalibrate a set point, indicative of
the stark increase in state regulation followed by
a stark decrease as shown in Eyler, et al.’s study
(2001). As the infant seeks a set point for homeostatic function, the final result would, when compared to unexposed infants, be lower in NBAS
scores. Due to the distressing environment in
utero and the change of environment postnatally,
a decrease in the state of regulation is an expected
result of adaptation when contrasted with the unexposed controls. This result is in accordance with
Eyler, et al.’s study (2001), indicative of an overall
effect of cocaine rather than cocaine withdrawal.
The Adaptationist View connects the data presented between Study A and Study B and also
satisfies a logical basis through which symptoms
arise from both studies. Yet, it formulates an
important objection to Study A: the presence of
in utero withdrawal. According to Ogunyemi &
Hernández-Loera’s study, their primary explana-
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tion was that cocaine– neonates tended to lack
withdrawal symptoms due to the withdrawal phase
occurring in utero (2004). When juxtaposing this
view with the Adaptationist view, there does not
leave much room as to when the neonate would
experience withdrawal prenatally. Though it can
be argued that in utero withdrawal occurs as the
neonate is adapting to the low resource environment, this environment and subsequent adaptation
is undertaken in the presence of cocaine; withdrawal, as considered in the addiction cycle, occurs when cocaine is absent (Herman & Roberto
2015; Eyler, et al. 2001). The unpleasurable
state sustained is the result of cocaine affecting the
mother’s sympathetic system, hindering the optimal nutrients needed in neonate growth and development. Thus, in utero withdrawal is not compatible with the Adaptationist view.
When considering Study A, the argument in
favor of withdrawal is supported as a pathophysiological function, where each neurobehavioral
symptom can be derived when observing this
view. When considering Study B, the Adaptationist View can explain how cocaine leads to an overall effect on the infants, i.e. lower amounts of oxygen and nutrients and rapid changes in environment, rather than withdrawal specifically. Thus,
in application, the Adaptationist View very aptly
connects the differences within Studies A and B
and lines up with the conclusion made by Study B.
Yet, by rejecting the presence of in utero cocaine
withdrawal, there is no explanation as to why
withdrawal-like symptoms are present in some
cocaine-exposed neonates but not others. Moreover, if the symptoms that were present postnatally are the effects of neonate cocaine withdrawal,
there must be an explanation as to why withdrawal
is selective to one cocaine-exposed population but
not the latter.
Though I united the results of both studies to
support the notion of an overall effect of cocaine,
the following scenario must be addressed: When
neonates are exposed to cocaine repeatedly over
the course of a pregnancy if cocaine is suddenly
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removed, as is the case after birth, shouldn’t the
infant experience withdrawal symptoms, considering that cocaine is an addictive substance? This
scenario falls in line with the ACC presented in the
introduction. As commonsensical as the argument
may be, I will offer a solution that may circumvent
this discrepancy between cocaine addiction and
neonate withdrawal. The infant may experience
some variant of selective attention, where there
is a stronger negative effect experienced directly
from cocaine than there is from withdrawal. In
essence, the negative stimuli attributed to the overall effects of cocaine are perceived stronger than
the negative distractor stimuli attributed to withdrawal (Johansen-Berg & Lloyd 2000). If there is
withdrawal within a cocaine-exposed neonate, its
effects are secondary to the direct effects of cocaine and the body physiologically reacts to the
stronger stimulant. Thus, the ACC may be accepted in this context. Note that this conclusion
does not undermine the Adaptationist View but
rather provides an explanation as to why some
cocaine-exposed infants did not experience withdrawal symptoms. The complication that arises is
that the scales used to diagnose cNAS are actually
diagnosing the overall effects of cocaine. In effect, these scales are not sensitive enough to capture less stimulating cNAS. Without any data on
borderline cases of NAS, i.e. cases where their
score was minutely below the threshold for diagnosis, this concern may hold. More studies, however, need to be done to verify that this complication is present.
Both studies support the Adaptationist View
by equating the symptoms commonly attributed
to cNAS to the adaption of an infant to a new,
higher oxygen environment. This view continues
by attributing the extreme increases and decreases
in NBAS scores for autonomic regulation to be
the result of seeking a setpoint for homeostasis.
Thus, withdrawal is not primarily evident and both
studies would support the presence of an adaptation mechanism that points to the direct effects of
cocaine. In introducing the ACC, the presence
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of withdrawal may be still be possible but secondary to the overall effects of cocaine, causing
the lack of an identifiable physiological response
for NAS. When considering NAS in the context of
the Adaptationist View and ACC, the argument in
favor of the direct effects of cocaine on the infant
is strengthened but the presence of withdrawal remains logically possible.
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